The global dermatology excimer laser market size was valued at USD 390.5 million in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2021 to 2028. Excimer 308 nm laser is a form of targeted phototherapy that delivers specific wavelengths of ultraviolet B (UVB) radiation. These lasers deliver UVB light to affected areas of the skin while leaving healthy skin tissues unaffected. Excimer lasers are highly customizable and have different handpieces that enable providers to administer the specific level of UV wavelengths needed by each patient. These lasers have been proven effective in treating skin conditions like vitiligo, psoriasis, atopic dermatitis, etc. with high success and low recurrence rates.
Although the COVID-19 pandemic had a major impact on the global market, many aesthetic professionals believe that pandemics might most likely propel the overall aesthetic market. Many dermatology clinics have witnessed a boost in the number of future appointments and consultations for different skin treatments and this is expected to boost the market growth. The rising incidence of skin conditions like psoriasis and vitiligo across the globe is anticipated to drive the global market. Improved safety and efficacy of these techniques and devices resulting in the high success rate of the procedure are also expected to boost their demand.
Initiatives, such as M&A, novel product launches, and partnerships, undertaken by major companies for product research and distribution are expected to drive the market further in the coming years. In the U.S. market, the trolley-mounted excimer lasers segment is expected to grow at a CAGR of 10.5% from 2021 to 2028. Excimer laser treatment is a phototherapy technique that is performed by a trained medical assistant, is virtually painless, and is safe for children as well. Major factors driving market growth include the rising prevalence of different chronic skin conditions and the non-invasive nature of excimer treatments, as the patient requires no downtime after completion of the procedure.
Xtrac, developed by Strata Skin Sciences., is an FDA-approved excimer laser technology that has proven effective to treat vitiligo, psoriasis, atopic dermatitis, and Leukoderma. More than five million patients have been successfully treated with Xtracexcimer lasers globally. According to National Psoriasis Foundation, around 125 million (1%-2%) people are affected with psoriasis globally as of 2019. According to Strata Skin Sciences, 35 million people suffer from skin conditions like psoriasis, vitiligo, eczema, atopic dermatitis, and Leukoderma in the U.S. alone, and the incidence of these diseases is expected to increase in the future.
These factors are expected to propel market growth. The advent of the COVID-19 pandemic had affected the overall aesthetic and dermatology market. All invasive and noninvasive esthetic procedures were severely affected amid the pandemic; this includes the dermatology excimer laser market. According to Wiley One Library, the pandemic had affected dermatology practices globally leading to limiting the number of patients visiting dermatology clinics. However, many countries have allowed resuming of dermatology and aesthetic clinics under strict COVID-19 protocols.
The trolley-mounted excimer lasers segment held the largest revenue share of 43.3% in 2020. Based on type, the market has been segmented into tabletop excimer lasers, hand-held excimer lasers, and trolley mounted excimer lasers. The segment is expected to maintain the leading position during the forecast period. This is because trolley-mounted lasers are portable, can be transported easily, and can be placed in any corner of a dermatology clinic. The advent of various products, investments by market players, and high demand for noninvasive skin treatment procedures due to their safe and cost-effective nature are some of the factors driving the segment growth.
Some examples of trolley-mounted laser excimer devices are Pharos by Ra Medical Systems and Xtrac by Strata Skin Sciences. Strata Skin Sciences has reported that more than 2000 Xtrac devices have been installed worldwide and many medical academic institutes have also reported using the Xtrac laser system. The hand-held device segment is also expected to hold a significant market share during the forecast period as these devices provide the benefits of a lighter weight system that offers flexibility and lower investment, operation, & maintenance costs. Alma laser develops and manufactures EXCIMER 308 system, which is a handheld device and can be stored and transported in its compact carrying case.
The psoriasis application segment held the highest market share of 22.1% in 2020 and is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the fact that the prevalence of psoriasis is on the rise. The U.S. alone has around 8 million people suffering from this skin condition. The WHO has also stated that psoriasis is a serious global problem with more than 100 million individuals affected worldwide. Moreover, excimer lasers are proven effective for the treatment of this condition with a success rate of 72%, which has led to segment growth.
Based on application the market has been segmented into psoriasis, vitiligo, atopic dermatitis, allergic rhinitis, alopecia areata, and others. The Atopic Dermatitis (AD) segment also held a significant market share in 2020. Atopic dermatitis, a common chronic or recurrent inflammatory skin disease, affects 15-20% of children and 1-2% of adults globally. In the U.S., around 7.3% of adults have AD and 40% of them have moderate to severe symptoms. As excimer lasers are safe to use on adults as well as children and as the prevalence of skin conditions is increasing, the demand for dermatology excimer lasers treatment has also witnessed growth.
North America dominated the global market with a share of over 37% in 2020 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the rising prevalence of skin conditions, well-established medical infrastructure & reimbursement policies, presence of key market players, and high adoption of novel aesthetic procedures. Moreover, high acceptance and openness towards aesthetic treatments and a rising appearance-conscious population are likely to support the market growth in the region.
The APAC regional market is expected to witness the fastest CAGR of 11.4% over the forecast period. Asian countries, such as China, Japan, and India, are emerging economies with well-developed healthcare infrastructure and facilities and are now more focused on leading on the basis of R&D activities. Such countries have been a long renowned hub for aesthetic procedures. Annually, numerous skin treatment procedures are carried out in countries like China, South Korea, and Japan. Moreover, cost-effective and high-quality treatment, high disposable income& cases of skin conditions like atopic dermatitis and psoriasis are driving the market in the APAC region.
A prominent number of market players are rapidly opting for geographical expansion, strategic collaborations, and partnerships through mergers and acquisitions in emerging and economically favorable regions. In March 2021, Strata Skin Sciences announced an expanded direct distribution agreement with Wuhan Miracle Laser Systems, Inc. This agreement is expected to strengthen the company’s laser excimer business in China. Also, in January 2021, Strata Skin Sciences introduced the “Home by XTRAC” business that provides at-home, insurance-reimbursed treatment options for patients with certain skin diseases that do not qualify for in-office treatments. Some of the key players in the global dermatology excimer laser market are:
Ra Medical Systems
Shenzhen GSD Tech Co., Ltd.
Alma Lasers (Shanghai FosunPharmaceutical Group Co., Ltd.)
Strata Skin Sciences, Inc.
The Daavlin Company
Report Attribute |
Details |
Market size value in 2021 |
USD 490.42 million |
Revenue forecast in 2028 |
USD 955.57 million |
Growth rate |
10.00% |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Brazil; Mexico; Argentina; China; India; Japan; Australia; South Korea; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Ra Medical Systems; Shenzhen GSD Tech Co., Ltd.; Alma Lasers (Shanghai Fosun Pharmaceutical Group Co., Ltd.); Strata Skin Sciences, Inc.; The Daavlin Company |
Customization scope |
Free report customization (equivalent to up to 8 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global dermatology excimer laser market report on the basis of product, application, and region:
Product Outlook (Revenue, USD Million, 2016 - 2028)
Table top Excimer Lasers
Hand-held Excimer Lasers
Trolley Mounted Excimer Lasers
Application Outlook (Revenue, USD Million, 2016 - 2028)
Psoriasis
Vitiligo
Atopic Dermatitis
Allergic Rhinitis
Alopecia Areata
Others
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Asia Pacific
India
Japan
China
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global dermatology excimer laser market size was estimated at USD 390.5 million in 2020 and is expected to reach USD 490.42 million in 2021
b. The global dermatology excimer laser market is expected to grow at a compound annual growth rate of 10.0% from 2021 to 2028 to reach USD 955.5 million by 2028.
b. North America dominated the dermatology excimer laser market with a share of 37.9% in 2020. This is attributed to the rising prevalence of skin conditions among the population, strong medical infrastructure, well-established reimbursement policies, the existence of key market players, and high adoption of novel aesthetic procedures
b. Some key players operating in the dermatology excimer laser market include Cynosure, Inc.; Ra Medical Systems, Shenzhen GSD Tech Co., Ltd, Alma Lasers (Shanghai Fosun Pharmaceutical Group Co., Ltd.), Strata Skin Sciences Inc, The Daavlin Company.
b. Key factors that are driving the market growth include rising incidence of skin conditions like psoriasis and vitiligo across the globe are anticipated to drive the global market. Improved safety and efficacy of these techniques and devices resulting in a high success rate of the procedure are also expected to boost their demand
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.